News

Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when ...
There is a mystical aspect about teddy bears in that they provide unconditional love. They are symbols of love. When a cancer ...
STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell ...
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while ...
Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...
A patient and provider share updates on pelabresib plus Rituxan treatment, which met the MANIFEST-2 trial's primary end point ...
Christine Simonelli, B.S.N., RN, CCRC, OCN, is amazing, and goes out of her way to help patients and providers.
The FDA has accepted and granted priority review to an NDA for sevabertinib in previously treated HER2+ non-small cell lung ...
I want my family to understand our shared cancer risks, but I sometimes struggle to face the painful reality of the disease ...
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining ...
The BLA seeking accelerated approval for patritumab deruxtecan in previously treated, locally advanced EGFR-mutated NSCLC in ...
Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help ...